BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 32763327)

  • 1. Long-term outcomes of Mohs micrographic surgery for invasive melanoma of the trunk and proximal portion of the extremities.
    Burnett ME; Brodland DG; Zitelli JA
    J Am Acad Dermatol; 2021 Mar; 84(3):661-668. PubMed ID: 32763327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of Mohs micrographic surgery (MMS) for melanoma in situ (MIS) of the trunk and proximal extremities.
    Stigall LE; Brodland DG; Zitelli JA
    J Am Acad Dermatol; 2016 Nov; 75(5):1015-1021. PubMed ID: 27473456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Controversy and Value of Mohs Micrographic Surgery for Melanoma and Melanoma in Situ on the Trunk and Extremities.
    Zitelli JA; Stiegel E; Brodland DG
    Dermatol Surg; 2023 Dec; 49(12):1061-1065. PubMed ID: 37962134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow Mohs Micrographic Surgery for Acral Melanoma Treatment in Korean Patients.
    Seo J; Oh Y; Kim SK; Roh MR; Chung KY
    Dermatol Surg; 2021 Feb; 47(2):e42-e46. PubMed ID: 33481431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Mohs Micrographic Surgery vs Wide Local Excision With Overall Survival Outcomes for Patients With Melanoma of the Trunk and Extremities.
    Demer AM; Hanson JL; Maher IA; Liszewski W
    JAMA Dermatol; 2021 Jan; 157(1):84-89. PubMed ID: 33084853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating melanoma in situ and lentigo maligna with Mohs micrographic surgery in Australia.
    Foxton GC; Elliott TG; Litterick KA
    Australas J Dermatol; 2019 Feb; 60(1):33-37. PubMed ID: 29932208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mohs micrographic surgery for the treatment of primary cutaneous melanoma.
    Zitelli JA; Brown C; Hanusa BH
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 1):236-45. PubMed ID: 9270510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous head and neck melanoma treated with Mohs micrographic surgery.
    Bricca GM; Brodland DG; Ren D; Zitelli JA
    J Am Acad Dermatol; 2005 Jan; 52(1):92-100. PubMed ID: 15627086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morbidity and Mortality of Melanoma on the Trunk and Extremities Treated With Mohs Surgery Versus Wide Excision: A Systematic Review.
    Bednar ED; Zon M; Abu-Hilal M
    Dermatol Surg; 2022 Jan; 48(1):1-6. PubMed ID: 34608076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of outcomes for malignant melanoma of the face treated using Mohs micrographic surgery and wide local excision.
    Chin-Lenn L; Murynka T; McKinnon JG; Arlette JP
    Dermatol Surg; 2013 Nov; 39(11):1637-45. PubMed ID: 24164702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mohs Micrographic Surgery Using MART-1 Immunostain in the Treatment of Invasive Melanoma and Melanoma In Situ.
    Valentín-Nogueras SM; Brodland DG; Zitelli JA; González-Sepúlveda L; Nazario CM
    Dermatol Surg; 2016 Jun; 42(6):733-44. PubMed ID: 27158886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wide local excision prior to sentinel lymph node biopsy for primary melanoma of the head and neck.
    May MM; Lohse CM; Moore EJ; Price DL; Van Abel KM; Brewer JD; Janus JR
    Int J Dermatol; 2019 Oct; 58(10):1184-1190. PubMed ID: 30968948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical margins for excision of primary cutaneous melanoma.
    Zitelli JA; Brown CD; Hanusa BH
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):422-9. PubMed ID: 9308558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of a multiinstitutional series with an analysis of the extent of microscopic spread.
    Ratner D; Thomas CO; Johnson TM; Sondak VK; Hamilton TA; Nelson BR; Swanson NA; Garcia C; Clark RE; Grande DJ
    J Am Acad Dermatol; 1997 Oct; 37(4):600-13. PubMed ID: 9344201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mohs micrographic surgery for melanoma: A prospective multicenter study.
    Ellison PM; Zitelli JA; Brodland DG
    J Am Acad Dermatol; 2019 Sep; 81(3):767-774. PubMed ID: 31150700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive Melanoma and Melanoma in Situ Treated With Modified Mohs Micrographic Surgery With En Face Permanent Sectioning: A 10-Year Retrospective Review.
    Heath M; Woody M; Leitenberger J; Latour E; Bar A
    Dermatol Surg; 2020 Aug; 46(8):1004-1013. PubMed ID: 31714384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis.
    Haigh PI; DiFronzo LA; McCready DR
    Can J Surg; 2003 Dec; 46(6):419-26. PubMed ID: 14680348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in intermediate-risk squamous cell carcinomas treated with Mohs micrographic surgery compared with wide local excision.
    Xiong DD; Beal BT; Varra V; Rodriguez M; Cundall H; Woody NM; Vidimos AT; Koyfman SA; Knackstedt TJ
    J Am Acad Dermatol; 2020 May; 82(5):1195-1204. PubMed ID: 31887322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mohs micrographic surgery: a cost analysis.
    Cook J; Zitelli JA
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment.
    Etzkorn JR; Sobanko JF; Elenitsas R; Newman JG; Goldbach H; Shin TM; Miller CJ
    J Am Acad Dermatol; 2015 May; 72(5):840-50. PubMed ID: 25774012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.